Showing results (11-20 of 54) with videos related to
Sort By:
Pageof 6
Onkologie|July 8, 2011
Quality assured health care in certified breast centers and improvement of the prognosis of breast cancer patientsMatthias W Beckmann, Cosima Brucker, Volker Hanf, et al.Geburtshilfe Und Frauenheilkunde|August 29, 2017
Should Breast Cancer Surgery Be Done in an Outpatient Setting?: Health Economics From the Perspective of Service ProvidersMargaret Formago, Michael G Schrauder, Claudia Rauh, et al.Geburtshilfe Und Frauenheilkunde|July 18, 2017
A Standard Mammography Unit - Standard 3D Ultrasound Probe Fusion Prototype: First ResultsRüdiger Schulz-Wendtland, Sebastian M Jud, Peter A Fasching, et al.Acta Radiologica (Stockholm, Sweden : 1987)|March 3, 2018
Initial clinical results with a fusion prototype for mammography and three-dimensional ultrasound with a standard mammography system and a standard ultrasound probeJulius Emons, Marius Wunderle, Arndt Hartmann, et al.Breast Cancer Research and Treatment|July 31, 2009
Pain perception and detailed visual pain mapping in breast cancer survivorsSebastian M Jud, Peter A Fasching, Christian Maihöfner, et al.Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|December 11, 2012
Major histocompatibility complex class II polymorphisms are associated with the development of anti-resorptive agent-induced osteonecrosis of the jawPhilipp Stockmann, Emeka Nkenke, Matthias Englbrecht, et al.Breast (Edinburgh, Scotland)|April 4, 2009
Ki-67 as a prognostic molecular marker in routine clinical use in breast cancer patientsFolkward G Wiesner, Achim Magener, Peter A Fasching, et al.Frontiers in Oncology|October 28, 2024
Incidental findings of borderline ovarian tumor or ovarian cancer - real-world data on surgical and oncological outcomesCarmen Joder, Celine Smaadahl-Wey, Lara Zumwald, et al.Archives of Gynecology and Obstetrics|September 8, 2012
Prognostic molecular markers and neoadjuvant therapy response in anthracycline-treated breast cancer patientsDavid L Wachter, Peter A Fasching, Lothar Haeberle, et al.Anticancer Research|January 2, 2016
Mitomycin C and Capecitabine (MiX Trial) for Therapy of Patients with Metastasized, Breast Cancer Pretreated with AnthracyclineKatrin Almstedt, Peter A Fasching, Anton Scharl, et al.Pageof 6